Recombinant human interleukin 10 for induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews

Volumn 2012, Issue 1, 2010, Pages

  Buruiana, Felicia Elena ^a   Solà, Ivan ^b   Alonso Coello, Pablo ^c  

^a PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

^b BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; RECOMBINANT PROTEIN;

CROHN DISEASE; HUMAN; META ANALYSIS; PATIENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; STATISTICS;

CROHN DISEASE; HUMANS; INTERLEUKIN-10; PATIENT DROPOUTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; REMISSION INDUCTION;

EID: 79952052483     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005109.pub3     Document Type: Article

References (17)

1. Fedorak RN, Gangl A, Elson CO, Rutgeerts P, Schreiber S, Wild G, et al. Recombinant human interleukin 10 in the treatment of patients with mild to moderately severe active Crohns disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology 2000;119(6):1473-82.
2. Schreiber S, Fedorak RN, Nielsen OH, Wild G, Williams CN, Nikolaus S, et al. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology 2000;19(6):1461-72.
3. Van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology 1997;113(2):383-9.
4. Colombel JF, Rutgeerts P, Malchow H, Jacyna M, Nielsen OH, Rask-Madsen J, et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 2001;49(1):42-6.
5. de Villiers WJ. Crohn's disease and IL-10 therapy: promise regained. Inflamm Bowel Dis 2003;9(3):210-1.
6. Dejaco C, Tilg H, Gasche C. In vivo changes of lymphocyte subpopulations and leukocyte surface markers by multiple doses of recombinant human interleukin-10 in inflammatory bowel disease. Gastroenterology 1998;114(Suppl 1):A961.
7. Geier MS, Butler RN, Howarth GS. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol 2007;115(1):1-11.
8. Schreiber S. Novel and future strategies in the management of IBD. Annals of Gastroenterology 2002;15(4):307.
9. Tilg H, Kaser A, Schreiber S, Gregor M, Rutgeerts P, van Deventer S, et al. New insights into the pathogenesis of anemia of chronic diseases: induction of ferritin synthesis and development of anemia during recombinant human interleukin-10 (rHuIL-10) treatment of chronic active Crohn's disease (CACD). Gastroenterology 1998;114(Suppl 1):A1100.
10. Tilg H, Kaser A, Propst A, Schreiber S, Gregor M, Rutgeerts P, et al. Recombinant human interleukin-10 (rHuIL-10) therapy in steroid-refractory chronic active Crohns disease (CACD): induction of neopterin, a degradation product of the pteridine pathway regulated by interferon-gamma. Gastroenterology 1998;114(Suppl 1):A1100.
11. Tilg H, van Montfrans C, van den Ende A, Kaser A, van Deventer SJ, Schreiber S, et al. Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut 2002;50(2):191-5.
12. Tilg H, Ulmer H, Kaser A, Weiss G. Role of IL-10 for induction of anemia during inflammation. J Immunol 2002;169(4):2204-9.
13. Autschbach F, Braunstein J, Helmke B, Zuna I, Schumann G, Niemir ZI, et al. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol 1998;153(1):121-30.
14. Farrell RJ, Peppercorn MA. Medical management of Crohn's disease in adults. Am J Gastroenterol 1989;84:249.
15. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6.
16. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1[updated September 2008]. The Cochrane Collaboration. Chichester, UK: John Wiley & Sons, Ltd, 2008.
17. Joshua R Korzenik, Daniel K Podolski. Evolving knowledge and therapy of inflammatory bowel disease. Nature Reviews 2006;5:197-209.